BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Curry MP, Hegarty JE. The gallbladder and biliary tract in cystic fibrosis. Curr Gastroenterol Rep 2005;7:147-53. [PMID: 15802104 DOI: 10.1007/s11894-005-0053-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Assis DN, Debray D. Gallbladder and bile duct disease in Cystic Fibrosis.J Cyst Fibros. 2017;16 Suppl 2:S62-S69. [PMID: 28986023 DOI: 10.1016/j.jcf.2017.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
2 Balistreri WF, Bezerra JA. Whatever Happened to “Neonatal Hepatitis”? Clinics in Liver Disease 2006;10:27-53. [DOI: 10.1016/j.cld.2005.10.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
3 Coleman WB, Tsongalis GJ. Understanding molecular pathogenesis: the biological basis of human disease and implications for improved treatment of human disease. Essential Concepts in Molecular Pathology. Elsevier; 2020. pp. 191-200. [DOI: 10.1016/b978-0-12-813257-9.00012-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lafoeste H, Regard L, Martin C, Chassagnon G, Burgel P. Complications aiguës respiratoires et non respiratoires chez l’adulte mucoviscidosique. Revue de Pneumologie Clinique 2018;74:267-78. [DOI: 10.1016/j.pneumo.2018.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Safirstein J, Grant JJ, Clausen E, Savant D, Dezube R, Hong G. Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis. J Cyst Fibros 2021;20:506-10. [PMID: 32736949 DOI: 10.1016/j.jcf.2020.07.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Babakhanian Z, Donovan JA. Biliary manifestations of systemic diseases. Gastrointest Endosc Clin N Am 2013;23:333-46. [PMID: 23540964 DOI: 10.1016/j.giec.2012.12.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Dana J, Debray D, Beaufrère A, Hillaire S, Fabre M, Reinhold C, Baumert T, Berteloot L, Vilgrain V. Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies. J Hepatol 2021:S0168-8278(21)02115-2. [PMID: 34678405 DOI: 10.1016/j.jhep.2021.09.042] [Reference Citation Analysis]
8 Thakur UK, Raypattanaik NM, Kumar M, Tandup C, Kaman L. Micro-gallbladder: A rare surgical problem. Trop Doct 2021;:49475521998182. [PMID: 33657938 DOI: 10.1177/0049475521998182] [Reference Citation Analysis]
9 Kremer TM, Zwerdling RG, Michelson PH, O'Sullivan P. Intensive care management of the patient with cystic fibrosis. J Intensive Care Med 2008;23:159-77. [PMID: 18443012 DOI: 10.1177/0885066608315679] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
10 Regard L, Martin C, Chassagnon G, Burgel PR. Acute and chronic non-pulmonary complications in adults with cystic fibrosis. Expert Rev Respir Med 2019;13:23-38. [PMID: 30472915 DOI: 10.1080/17476348.2019.1552832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Poetter-Lang S, Staufer K, Baltzer P, Tamandl D, Muin D, Bastati N, Halilbasic E, Hodge JC, Trauner M, Kazemi-Shirazi L, Ba-Ssalamah A. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study. Eur Radiol 2019;29:1048-58. [PMID: 30054796 DOI: 10.1007/s00330-018-5650-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zarei K, Stroik MR, Gansemer ND, Thurman AL, Ostedgaard LS, Ernst SE, Thornell IM, Powers LS, Pezzulo AA, Meyerholz DK, Stoltz DA. Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model. Lab Invest 2020;100:1388-99. [PMID: 32719544 DOI: 10.1038/s41374-020-0474-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Glaser S, Francis H, DeMorrow S, LeSage G, Fava G, Marzioni M, Venter J, Alpini G. Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol 2006; 12(22): 3523-3536 [PMID: 16773709 DOI: 10.3748/wjg.v12.i22.3523] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
14 Kotb MA. Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. Int J Mol Sci 2012;13:8882-914. [PMID: 22942741 DOI: 10.3390/ijms13078882] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
15 Ceulemans LJ, Strypstein S, Neyrinck A, Verleden S, Ruttens D, Monbaliu D, De Leyn P, Vanhaecke J, Meyns B, Nevens F, Verleden G, Van Raemdonck D, Pirenne J. Combined liver-thoracic transplantation: single-center experience with introduction of the ‘Liver-first’ principle. Transpl Int 2016;29:715-26. [DOI: 10.1111/tri.12781] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]